Zhe Xu

1.9k citations
99 papers · 937 indexed · h-index 18

Zhe Xu

90 papers receiving 923 citations

Peers

Zhe Xu
Comparison fields: 5 of 126
  • Pulmonary and Respiratory Medicine 233
  • Molecular Biology 393
  • Cell Biology 92
  • Cancer Research 64
  • Biochemistry 23
Replace Hiroto Suzuki with:
Hiroto Suzuki Japan
Di Chen China
Koji Yamamoto Japan
Ge Yang China
Yalong Wang China
Tae Gyu Choi South Korea
Leilei Xu China
Alka Bhatia India
Jie Bao China
Raquel Taléns‐Visconti Spain
Zhe Xu relative to Hiroto Suzuki Japan Hiroto Suzuki's profile →
Citations per field
00.5×
Hiroto Suzuki · 1×
Citations per year

Countries citing papers authored by Zhe Xu

Since Specialization
Citations

This map shows the geographic impact of Zhe Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhe Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhe Xu more than expected).

Fields of papers citing papers by Zhe Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhe Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhe Xu. The network helps show where Zhe Xu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Zhe Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zhe Xu Line = papers co-authored together Zhe Xu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20253
2 20250
3 20250
4 20250
5 20243
6 20243
7 202310
8 20236
9 20230
10 20232
11 202311
12 20237
13 202133
14 20214
15 20153
16
Research and Implementation of Field Crop Test Data Collection based on Mobile Phone
20131
17
Integrated monitoring of mosquitoes and mosquito-borne diseases in Zhejiang province.
20101
18 20101
19 200928
20
Measurement of permeability and Q-factor of ferrite toroids
20051

About Zhe Xu

Zhe Xu is a scholar working on Pharmaceutical Science, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 99 papers that have together received 937 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (7 papers), Drug Solubulity and Delivery Systems (5 papers), Neuroblastoma Research and Treatments (4 papers), Neonatal Respiratory Health Research (4 papers), Atrial Fibrillation Management and Outcomes (4 papers), Signaling Pathways in Disease (4 papers), Pharmacological Effects of Natural Compounds (3 papers) and Cardiac Arrhythmias and Treatments (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (233 citations), Molecular Biology (393 citations) and Cell Biology (92 citations). Zhe Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include David N. Sheppard, Zhiwei Cai, Margarida D. Amaral, André Schmidt, Yi Zhou, Cláudio M. Soares, Mário F. Neto, Mónica Roxo‐Rosa, Yuying Wu and Raed Rizkallah. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026